Riskpilot← Back to searchSign inGet full accessBorlänge Kiropraktik AB
ABActiveOrg 5567395321Röda Vägen 28 A 1tr Lgh 1201Physiotherapy activities · NACE 8695Est. 20071 employees
Revenue 2025
SEK 702K
-21% vs 2024
EBITDA margin
65.5%
-5% vs 2024
Equity ratio
75.3%
Financial strength
Net profit 2025
SEK 350K
-29% vs 2024
| Revenue | SEK 702K | -21% |
| EBITDA | SEK 460K | -5% |
| Net profit | SEK 350K | -29% |
| Total assets | SEK 1,9M | -3% |
| Equity | SEK 1,4M | -3% |
| Employees | 1 | — |
Legal name
Borlänge Kiropraktik AB
Org number
5567395321
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
9 oktober 2007
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget skall bedriva verksamhet inom annan öppen hälso och sjukvård, Bolaget skall även äga och förvalta fast och lös egendom samt idka handel med värdepapper och därmed förenlig verksamhet
Address
Röda Vägen 28 A 1tr Lgh 1201
Phone
+4624317877
Email
dan@borlangekiropraktik.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 062 | 563 | 983 | 886 | 702 |
| Staff expenses | — | −547 | −475 | −357 | −167 |
| EBITDA | 437 | −77 | 481 | 482 | 460 |
| Depreciation & amort. | −0 | — | −20 | −20 | −20 |
| EBIT | 437 | −77 | 461 | 463 | 440 |
| Net financials | — | −0 | 48 | 175 | 17 |
| Profit before tax | 437 | 73 | 509 | 637 | 458 |
| Tax | −107 | −25 | −113 | −141 | −108 |
| Net profit | 330 | 48 | 396 | 496 | 350 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 589 | 1 228 | 1 617 | 1 932 | 1 883 |
| Equity | 1 128 | 876 | 1 172 | 1 468 | 1 418 |
| Long-term debt | 0 | 19 | 87 | 37 | 61 |
| Short-term debt | 114 | 99 | 85 | 114 | 31 |
| Total debt | 114 | 118 | 173 | 151 | 92 |
EBITDA margin
65.5%
This company
15.8%
Market median
+315% vs market
20212025
Equity ratio
75.3%
This company
38.2%
Market median
+97% vs market
20212025
Return on equity
24.7%
This company
18.4%
Market median
+34% vs market
20212025
Net profit margin
49.8%
This company
8.1%
Market median
+515% vs market
20212025
Asset turnover
0.37×
This company
1.12×
Market median
-67% vs market
20212025
Debt / equity
0.33×
This company
0.62×
Market median
+47% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Borlänge Kiropraktik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dan Doverdal | Board of Directors | 0 companies |
| Dan Richard Öhman | Deputy Board Member | 0 companies |